Spotlighting undiscovered companies with enormous upside potential.
Contact us:
(310) 299-1717
Spotlighting undiscovered companies with enormous upside potential.
Home
About
Tiny Gems
NewsRoom
Newsletter Archives
Events
Contact
Headlines
Freight Technologies Inc. (FRGT) CEO Underscores Commitment to Continued Growth in Letter to Shareholders
Diamond Lake Minerals Inc. (DLMI) Riding Growing Sea Swell Favoring Digital Assets, Security Tokens
Genprex Inc. (NASDAQ: GNPX) Granted Orphan Drug Designation in Small Cell Lung Cancer by FDA
Lexaria Bioscience Corp. (LEXX) Building a Global Presence with Superior Delivery Technology
Vision Marine Technologies Inc. (NASDAQ: VMAR) Is ‘One to Watch’
Home
/
NewsRoom
TinyGemsBreaks
Headline
Company of Focus
Date
TinyGemsBreaks – Mullen Automotive Inc. (NASDAQ: MULN) Announces Strategic Engagement of Basile Law Firm P.C.
Mullen Automotive Inc. (MULN)
December 4, 2023
TinyGemsBreaks — Vision Marine Technologies Inc. (NASDAQ: VMAR), Blue Water Boat Rental Partner in Florida Expansion Offering E-Motion(TM)-Equipped Rentals
Vision Marine Technologies Inc. (VMAR)
December 4, 2023
TinyGemsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Proprietary Tech Lowers Blood Glucose More Effectively than Branded GLP-1 drug Semaglutide Alone, Study Shows
Lexaria Bioscience Corp. (LEXX)
November 28, 2023
TinyGemsBreaks – Lexaria Bioscience Corp.’s (NASDAQ: LEXX) DehydraTECH(TM) Shown to Improve Oral Performance of GLP-1 Drug in Human Pilot Study
Lexaria Bioscience Corp. (LEXX)
November 27, 2023
TinyGemsBreaks – Safety Shot (NASDAQ: SHOT) Begins Scientific Study, Hires Securities Litigation Attorney
Safety Shot (SHOT)
November 27, 2023
View All TinyGemsBreaks
TinyGems Articles
Headline
Company of Focus
Date
Diamond Lake Minerals Inc. (DLMI) Riding Growing Sea Swell Favoring Digital Assets, Security Tokens
Diamond Lake Minerals Inc. (DLMI)
December 4, 2023
Vision Marine Technologies Inc. (NASDAQ: VMAR) Is ‘One to Watch’
Vision Marine Technologies Inc. (VMAR)
December 1, 2023
Lexaria Bioscience Corp. (NASDAQ: LEXX) Building a Global Presence with Superior Delivery Technology for Wide Range of Drugs and Active Pharmaceutical Ingredients
Lexaria Bioscience Corp. (LEXX)
December 1, 2023
Genprex Inc. (NASDAQ: GNPX) Granted Orphan Drug Designation in Small Cell Lung Cancer by FDA, Presented Data at Two October Events Focused on Lung Cancer
Genprex Inc. (GNPX)
November 22, 2023
Lexaria Bioscience Corp. (NASDAQ: LEXX) Looking to Generate Sizable License Revenue from IP Growth, Expanding Patent Suite
Lexaria Bioscience Corp. (LEXX)
November 20, 2023
View All Articles
Public Press Releases
Filter Releases
Sectors
Aerospace and Defense
Banking and Finance
Banking
Biotechnology
Internet
Media
Metal and Mineral
Chemicals
Computer
Consumer Goods
Pharmaceutical
Oil & Energy
Real Estate
Software
Energy
Entertainment
Food and Beverage
Healthcare
Telecommunications
Transportation
Utilities
Remove All Filters
Symbol
Release
Time
Source
{{ release.qmtopics.qmsymbol[0].symbol }}
{{ release.headline }}
{{ release.datetime | amDateFormat:'hh:mm A'}}
{{ release.source }}
Load More Articles
Contact us:
(310) 299-1717